SYCE1
gene geneOn this page
Also known as bA108K14.6CT76
Summary
SYCE1 (synaptonemal complex central element protein 1, HGNC:28852) is a protein-coding gene on chromosome 10q26.3, encoding Synaptonemal complex central element protein 1 (Q8N0S2). Major component of the transverse central element of synaptonemal complexes (SCS), formed between homologous chromosomes during meiotic prophase.
This gene encodes a member of the synaptonemal complex, which links homologous chromosomes during prophase I of meiosis. The tripartite structure of the complex is highly conserved amongst metazoans. It consists of two lateral elements and a central region formed by transverse elements and a central element. The protein encoded by this gene localizes to the central element and is required for initiation and elongation of the synapsis. Allelic variants of this gene have been associated with premature ovarian failure and spermatogenic failure. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 93426 — RefSeq curated summary.
At a glance
- Gene–disease (curated): premature ovarian failure 12 (Strong, GenCC) — +2 more curated relationships
- Clinical variants (ClinVar): 86 total — 10 pathogenic, 1 likely-pathogenic
- Phenotypes (HPO): 17
- MANE Select transcript:
NM_001143764
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28852 |
| Approved symbol | SYCE1 |
| Name | synaptonemal complex central element protein 1 |
| Location | 10q26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA108K14.6, CT76 |
| Ensembl gene | ENSG00000171772 |
| Ensembl biotype | protein_coding |
| OMIM | 611486 |
| Entrez | 93426 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 9 protein_coding, 1 retained_intron
ENST00000303903, ENST00000343131, ENST00000368517, ENST00000432597, ENST00000479535, ENST00000863035, ENST00000863036, ENST00000863037, ENST00000863038, ENST00000863039
RefSeq mRNA: 3 — MANE Select: NM_001143764
NM_001143763, NM_001143764, NM_130784
CCDS: CCDS44500, CCDS7687
Canonical transcript exons
ENST00000343131 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001406300 | 133554847 | 133555129 |
| ENSE00003460587 | 133555351 | 133555438 |
| ENSE00003496944 | 133555981 | 133556047 |
| ENSE00003502031 | 133557067 | 133557156 |
| ENSE00003512079 | 133560091 | 133560153 |
| ENSE00003519672 | 133555780 | 133555903 |
| ENSE00003540200 | 133558877 | 133558951 |
| ENSE00003557218 | 133559301 | 133559360 |
| ENSE00003592103 | 133558167 | 133558214 |
| ENSE00003614034 | 133557864 | 133557918 |
| ENSE00003617265 | 133565457 | 133565583 |
| ENSE00003622207 | 133555597 | 133555707 |
| ENSE00003673197 | 133556759 | 133556822 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 97.67.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0230 / max 248.9989, expressed in 222 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 112134 | 0.7095 | 193 |
| 112135 | 0.2034 | 55 |
| 112138 | 0.0410 | 9 |
| 112137 | 0.0388 | 5 |
| 112136 | 0.0303 | 3 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 97.67 | gold quality |
| left testis | UBERON:0004533 | 97.45 | gold quality |
| testis | UBERON:0000473 | 94.17 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.70 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 87.48 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 87.26 | gold quality |
| cerebellar cortex | UBERON:0002129 | 86.98 | gold quality |
| right frontal lobe | UBERON:0002810 | 86.82 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.24 | gold quality |
| cerebellum | UBERON:0002037 | 85.10 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 84.85 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 84.82 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 81.49 | gold quality |
| prefrontal cortex | UBERON:0000451 | 80.93 | gold quality |
| nucleus accumbens | UBERON:0001882 | 79.34 | gold quality |
| neocortex | UBERON:0001950 | 78.93 | gold quality |
| frontal cortex | UBERON:0001870 | 78.84 | gold quality |
| frontal lobe | UBERON:0016525 | 78.84 | gold quality |
| caudate nucleus | UBERON:0001873 | 78.57 | gold quality |
| amygdala | UBERON:0001876 | 78.50 | gold quality |
| putamen | UBERON:0001874 | 77.70 | gold quality |
| adult organism | UBERON:0007023 | 77.29 | gold quality |
| hypothalamus | UBERON:0001898 | 76.54 | gold quality |
| cerebral cortex | UBERON:0000956 | 76.42 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 74.39 | gold quality |
| brain | UBERON:0000955 | 74.20 | gold quality |
| forebrain | UBERON:0001890 | 73.95 | gold quality |
| sperm | CL:0000019 | 73.35 | gold quality |
| Ammon’s horn | UBERON:0001954 | 72.23 | gold quality |
| right lobe of liver | UBERON:0001114 | 71.45 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.99 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 8)
- Given the known function of the SYCE1 gene, we suggest that the nonsense mutation identified accounts for the primary ovarian insufficiency phenotype. (PMID:25062452)
- A mutation in SYCE1 is associated with non-obstructive azoospermia. (PMID:25899990)
- Structural core of SYCE1 is formed by amino acids 25-179, within N-terminal half of protein, which mediates SYCE1 dimerization. This alpha-helical core adopts curved coiled-coil structure of 20-nm length in which two chains are arranged in anti-parallel configuration. Structure is retained within full-length SYCE1, in which long C-termini adopt extended conformations to achieve an elongated molecule of over 50nm in length (PMID:30607510)
- The second mutation of SYCE1 gene associated with autosomal recessive nonobstructive azoospermia. (PMID:31916078)
- Consanguineous Chinese Familial Study Reveals that a Gross Deletion that Includes the SYCE1 Gene Region Is Associated with Premature Ovarian Insufficiency. (PMID:31925770)
- Targeted next-generation sequencing panel screening of 668 Chinese patients with non-obstructive azoospermia. (PMID:33728612)
- Novel copy number variations within SYCE1 caused meiotic arrest and non-obstructive azoospermia. (PMID:35718780)
- Novel Mutations Reduce Expression of Meiotic Regulators SYCE1 and BOLL in Testis of Azoospermic Men from West Bengal, India. (PMID:37957469)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-199g17.9 | ENSDARG00000076609 |
| mus_musculus | Syce1 | ENSMUSG00000025480 |
| rattus_norvegicus | Syce1 | ENSRNOG00000024073 |
Paralogs (1): SYCE1L (ENSG00000205078)
Protein
Protein identifiers
Synaptonemal complex central element protein 1 — Q8N0S2 (reviewed: Q8N0S2)
Alternative names: Cancer/testis antigen 76
All UniProt accessions (3): Q8N0S2, A0A0A0MT28, A0A0B4J1R9
UniProt curated annotations — full annotation on UniProt →
Function. Major component of the transverse central element of synaptonemal complexes (SCS), formed between homologous chromosomes during meiotic prophase. Requires SYCP1 in order to be incorporated into the central element. May have a role in the synaptonemal complex assembly, stabilization and recombination.
Subunit / interactions. Homodimer. Found in a complex with SYCP1 and SYCE2. Interacts with SYCP1, SYCE2 and SYCE3. Interacts with SIX6OS1.
Subcellular location. Nucleus. Chromosome.
Disease relevance. Premature ovarian failure 12 (POF12) [MIM:616947] An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. The disease is caused by variants affecting the gene represented in this entry. Spermatogenic failure, 15 (SPGF15) [MIM:616950] An infertility disorder caused by spermatogenesis defects and characterized by non-obstructive azoospermia due to complete meiotic maturation arrest. SPGF15 inheritance is autosomal recessive. The disease is caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the SYCE family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N0S2-1 | 1 | yes |
| Q8N0S2-2 | 2 | |
| Q8N0S2-3 | 3 |
RefSeq proteins (3): NP_001137235, NP_001137236, NP_570140 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026676 | SYCE1 | Family |
Pfam: PF15233
UniProt features (12 total): sequence variant 3, splice variant 3, region of interest 2, chain 1, sequence conflict 1, coiled-coil region 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N0S2-F1 | 79.04 | 0.58 |
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-1221632 | Meiotic synapsis |
| R-HSA-1474165 | Reproduction |
| R-HSA-1500620 | Meiosis |
| R-HSA-1640170 | Cell Cycle |
MSigDB gene sets: 102 (showing top):
GOBP_MEIOTIC_CHROMOSOME_SEGREGATION, GOBP_CHROMOSOME_ORGANIZATION, REACTOME_MEIOTIC_SYNAPSIS, GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION, GOBP_ORGANELLE_FISSION, GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE, LYF1_01, GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_HOMOLOGOUS_CHROMOSOME_PAIRING_AT_MEIOSIS, GOBP_NUCLEAR_CHROMOSOME_SEGREGATION, GOBP_MEIOTIC_CELL_CYCLE, GOBP_CELL_DIVISION, GOBP_CELL_CYCLE_PROCESS, GOBP_DNA_METABOLIC_PROCESS
GO Biological Process (4): synaptonemal complex assembly (GO:0007130), cell division (GO:0051301), meiotic cell cycle (GO:0051321), synaptonemal complex organization (GO:0070193)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): synaptonemal complex (GO:0000795), central element (GO:0000801), chromosome (GO:0005694), nucleus (GO:0005634), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Meiosis | 1 |
| Reproduction | 1 |
| Cell Cycle | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| homologous chromosome pairing at meiosis | 1 |
| cellular component assembly | 1 |
| chromosome organization involved in meiotic cell cycle | 1 |
| synaptonemal complex organization | 1 |
| cellular process | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| meiotic nuclear division | 1 |
| chromosome organization | 1 |
| binding | 1 |
| synaptonemal structure | 1 |
| synaptonemal complex | 1 |
| intracellular membraneless organelle | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
988 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SYCE1 | SYCE2 | Q6PIF2 | 999 |
| SYCE1 | SYCP1 | Q15431 | 996 |
| SYCE1 | TEX12 | Q9BXU0 | 987 |
| SYCE1 | SYCE3 | A1L190 | 973 |
| SYCE1 | SYCP3 | Q8IZU3 | 883 |
| SYCE1 | DAZL | Q92904 | 879 |
| SYCE1 | C14orf39 | Q8N1H7 | 863 |
| SYCE1 | HORMAD1 | Q86X24 | 833 |
| SYCE1 | STAG3 | Q9UJ98 | 828 |
| SYCE1 | SYCP2 | Q9BX26 | 810 |
| SYCE1 | SPO11 | Q9Y5K1 | 743 |
| SYCE1 | REC8 | O95072 | 734 |
| SYCE1 | HORMAD2 | Q8N7B1 | 723 |
| SYCE1 | MEI1 | Q5TIA1 | 717 |
| SYCE1 | MEIOB | Q8N635 | 700 |
IntAct
203 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SYCE1 | BFSP2 | psi-mi:“MI:0915”(physical association) | 0.810 |
| BFSP2 | SYCE1 | psi-mi:“MI:0915”(physical association) | 0.810 |
| SYCE1 | TPM3 | psi-mi:“MI:0915”(physical association) | 0.740 |
| TPM3 | SYCE1 | psi-mi:“MI:0915”(physical association) | 0.740 |
| SYCE1 | ALOX5 | psi-mi:“MI:0915”(physical association) | 0.720 |
| SYCE1 | TSG101 | psi-mi:“MI:0915”(physical association) | 0.720 |
| NME7 | SYCE1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ALOX5 | SYCE1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| SYCE1 | NME7 | psi-mi:“MI:0915”(physical association) | 0.720 |
| SYCE1 | CBY2 | psi-mi:“MI:0915”(physical association) | 0.700 |
| CBY2 | SYCE1 | psi-mi:“MI:0915”(physical association) | 0.700 |
BioGRID (143): SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid), SYCE1 (Two-hybrid)
ESM2 similar proteins: A1L443, A2IDD5, A4IFI1, A6NJZ7, A6NNL0, A6NNM3, A8MT33, B1AL46, D3Z5T1, O95153, Q2M3G4, Q2T9R2, Q3TVI4, Q3TYX8, Q49AM3, Q4KLY2, Q569K6, Q5JTD0, Q5JXC2, Q5SSQ6, Q5SW24, Q5VT03, Q5VZR2, Q6ZNE9, Q7TN08, Q7TNF8, Q7Z591, Q80VJ8, Q810H6, Q811T9, Q86SX3, Q8C963, Q8CB62, Q8CII8, Q8IVF1, Q8IXR5, Q8N0S2, Q8N137, Q8N205, Q8N6L0
Diamond homologs: A8MT33, Q32LK9, Q4R7J8, Q5D525, Q5XHZ2, Q8N0S2, Q9D495
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SYCE1 | “form complex” | Synaptonemal_complex | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
86 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 10 |
| Likely pathogenic | 1 |
| Uncertain significance | 42 |
| Likely benign | 15 |
| Benign | 13 |
Top pathogenic / likely-pathogenic (11)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1071187 | NM_001143764.3(SYCE1):c.449_452del (p.Lys150fs) | Pathogenic |
| 226122 | NM_001143764.3(SYCE1):c.721C>T (p.Gln241Ter) | Pathogenic |
| 226420 | NM_001143764.3(SYCE1):c.197-2A>G | Pathogenic |
| 4796749 | SYCE1, IVS4, G-A, +1 | Pathogenic |
| 4796750 | SYCE1, 2-BP DEL, 689TT | Pathogenic |
| 4796751 | NM_001143764.3(SYCE1):c.475G>A (p.Glu159Lys) | Pathogenic |
| 4796752 | NM_001143764.3(SYCE1):c.271+2T>C | Pathogenic |
| 4796753 | SYCE1, ARG52TER | Pathogenic |
| 4796754 | SYCE1, 1-BP DEL, NT675 | Pathogenic |
| 643186 | NM_001143764.3(SYCE1):c.455_456del (p.Arg152fs) | Pathogenic |
| 4796755 | NM_001143764.3(SYCE1):c.271+1G>A | Likely pathogenic |
SpliceAI
2037 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:133555345:GCTTA:G | donor_loss | 1.0000 |
| 10:133555346:CTTAC:C | donor_loss | 1.0000 |
| 10:133555347:TTA:T | donor_loss | 1.0000 |
| 10:133555348:TA:T | donor_loss | 1.0000 |
| 10:133555350:C:A | donor_loss | 1.0000 |
| 10:133555434:TCAGC:T | acceptor_gain | 1.0000 |
| 10:133555435:CAGC:C | acceptor_gain | 1.0000 |
| 10:133555435:CAGCC:C | acceptor_gain | 1.0000 |
| 10:133555436:AGC:A | acceptor_gain | 1.0000 |
| 10:133555437:GC:G | acceptor_gain | 1.0000 |
| 10:133555438:CC:C | acceptor_gain | 1.0000 |
| 10:133555439:C:A | acceptor_loss | 1.0000 |
| 10:133555439:C:CC | acceptor_gain | 1.0000 |
| 10:133555444:C:CT | acceptor_gain | 1.0000 |
| 10:133555445:A:T | acceptor_gain | 1.0000 |
| 10:133555453:G:C | acceptor_gain | 1.0000 |
| 10:133555453:G:GC | acceptor_gain | 1.0000 |
| 10:133555558:T:TA | donor_gain | 1.0000 |
| 10:133555594:CACCT:C | donor_loss | 1.0000 |
| 10:133555596:C:CT | donor_loss | 1.0000 |
| 10:133555596:CCT:C | donor_gain | 1.0000 |
| 10:133555703:GCTGC:G | acceptor_loss | 1.0000 |
| 10:133555704:CTGC:C | acceptor_gain | 1.0000 |
| 10:133555705:TGC:T | acceptor_gain | 1.0000 |
| 10:133555706:GCCTG:G | acceptor_loss | 1.0000 |
| 10:133555708:CTGG:C | acceptor_loss | 1.0000 |
| 10:133555709:T:G | acceptor_loss | 1.0000 |
| 10:133555778:A:AC | donor_gain | 1.0000 |
| 10:133555779:C:CC | donor_gain | 1.0000 |
| 10:133555779:CA:C | donor_gain | 1.0000 |
AlphaMissense
2310 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:133556813:G:C | F158L | 0.961 |
| 10:133556813:G:T | F158L | 0.961 |
| 10:133556815:A:G | F158L | 0.961 |
| 10:133559321:C:G | R59P | 0.948 |
| 10:133559301:C:G | A66P | 0.946 |
| 10:133555809:A:C | F230L | 0.937 |
| 10:133555809:A:T | F230L | 0.937 |
| 10:133555811:A:G | F230L | 0.937 |
| 10:133556793:A:G | L165P | 0.920 |
| 10:133559330:A:G | L56P | 0.913 |
| 10:133555800:G:C | S233R | 0.912 |
| 10:133555800:G:T | S233R | 0.912 |
| 10:133555802:T:G | S233R | 0.912 |
| 10:133555992:A:G | L195P | 0.912 |
| 10:133555679:C:G | A250P | 0.910 |
| 10:133556802:A:G | L162P | 0.903 |
| 10:133555699:A:G | F243S | 0.889 |
| 10:133558193:A:G | L98P | 0.885 |
| 10:133560120:A:G | L36S | 0.881 |
| 10:133556822:C:A | R155S | 0.875 |
| 10:133556822:C:G | R155S | 0.875 |
| 10:133557903:A:G | L112P | 0.873 |
| 10:133559318:A:G | I60T | 0.867 |
| 10:133555793:C:G | A236P | 0.865 |
| 10:133557912:A:G | L109P | 0.863 |
| 10:133560099:A:G | L43P | 0.859 |
| 10:133558897:A:G | L84P | 0.852 |
| 10:133555698:A:C | F243L | 0.845 |
| 10:133555698:A:T | F243L | 0.845 |
| 10:133555700:A:G | F243L | 0.845 |
dbSNP variants (sampled 300 via entrez): RS1000229351 (10:133560646 T>A,C), RS1000281659 (10:133560363 C>T), RS1000781575 (10:133565727 G>C), RS1001129156 (10:133565867 T>C), RS1001811851 (10:133566580 G>A), RS1001851983 (10:133555256 G>A,C), RS1002015005 (10:133565333 C>T), RS1002256007 (10:133556131 T>C), RS1002544748 (10:133565620 G>A,C), RS1002674477 (10:133560342 C>A,T), RS1002818355 (10:133565713 A>C,G), RS1002940418 (10:133553789 C>G), RS1003250408 (10:133564773 C>T), RS1003301105 (10:133564608 G>A,T), RS1003326471 (10:133553447 A>T)
Disease associations
OMIM: gene MIM:611486 | disease phenotypes: MIM:616947, MIM:616950
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| premature ovarian failure 12 | Strong | Autosomal recessive |
| spermatogenic failure 15 | Strong | Autosomal recessive |
| male infertility with azoospermia or oligozoospermia due to single gene mutation | Supportive | Autosomal dominant |
Mondo (3): premature ovarian failure 12 (MONDO:0014844), spermatogenic failure 15 (MONDO:0014847), (MONDO:0018393)
Orphanet (0):
HPO phenotypes
17 total (17 of 17 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000027 | Azoospermia |
| HP:0000118 | Phenotypic abnormality |
| HP:0000568 | Microphthalmia |
| HP:0000786 | Primary amenorrhea |
| HP:0000837 | Increased circulating gonadotropin level |
| HP:0003251 | Male infertility |
| HP:0007754 | Macular dystrophy |
| HP:0008669 | Abnormal spermatogenesis |
| HP:0008734 | Decreased testicular size |
| HP:0011462 | Young adult onset |
| HP:0011961 | Non-obstructive azoospermia |
| HP:0011962 | Obstructive azoospermia |
| HP:0030087 | Abnormal circulating testosterone concentration |
| HP:0030345 | Abnormal circulating luteinizing hormone concentration |
| HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration |
| HP:0031038 | Spermatogenesis maturation arrest |
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
1 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT04009473 | PHASE1/PHASE2 | UNKNOWN | Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation |
Related Atlas pages
- Associated diseases: premature ovarian failure 12, spermatogenic failure 15
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): premature ovarian failure 12, spermatogenic failure 15